AIRLINK 59.57 Decreased By ▼ -0.13 (-0.22%)
BOP 6.31 Increased By ▲ 0.05 (0.8%)
CNERGY 4.34 Increased By ▲ 0.07 (1.64%)
DFML 15.80 Increased By ▲ 0.10 (0.64%)
DGKC 69.30 Increased By ▲ 0.10 (0.14%)
FCCL 18.42 Increased By ▲ 0.07 (0.38%)
FFBL 26.95 Increased By ▲ 0.20 (0.75%)
FFL 9.25 Decreased By ▼ -0.03 (-0.32%)
GGL 10.24 Decreased By ▼ -0.06 (-0.58%)
HBL 116.87 Increased By ▲ 0.97 (0.84%)
HUBC 114.50 Increased By ▲ 0.10 (0.09%)
HUMNL 6.77 Decreased By ▼ -0.03 (-0.44%)
KEL 4.94 Increased By ▲ 0.05 (1.02%)
KOSM 4.63 Decreased By ▼ -0.02 (-0.43%)
MLCF 38.30 Decreased By ▼ -0.09 (-0.23%)
OGDC 124.26 Decreased By ▼ -1.04 (-0.83%)
PAEL 21.65 Increased By ▲ 0.09 (0.42%)
PIAA 11.07 Increased By ▲ 0.20 (1.84%)
PIBTL 6.05 Increased By ▲ 0.03 (0.5%)
PPL 112.70 Decreased By ▼ -1.40 (-1.23%)
PRL 28.17 Increased By ▲ 0.27 (0.97%)
PTC 10.94 Increased By ▲ 0.04 (0.37%)
SEARL 50.56 Decreased By ▼ -1.14 (-2.21%)
SNGP 67.15 Decreased By ▼ -1.11 (-1.63%)
SSGC 11.25 Decreased By ▼ -0.17 (-1.49%)
TELE 7.83 Increased By ▲ 0.03 (0.38%)
TPLP 11.65 Increased By ▲ 0.05 (0.43%)
TRG 72.89 Increased By ▲ 0.02 (0.03%)
UNITY 23.65 Increased By ▲ 0.10 (0.42%)
WTL 1.30 No Change ▼ 0.00 (0%)
BR100 6,659 Increased By 10.2 (0.15%)
BR30 22,557 Decreased By -12.4 (-0.06%)
KSE100 64,684 Increased By 105 (0.16%)
KSE30 21,942 Increased By 53 (0.24%)
Business & Finance

Moderna sees $18.4bn in sales from COVID-19 vaccine in 2021

  • Moderna also said Chief Medical Officer Tal Zaks would leave the company in late September.
  • Moderna on Wednesday said it was expecting to produce 700 million doses in 2021, while attempting to scale up production to as much as 1 billion doses.
Published February 25, 2021

Moderna Inc said on Thursday it was expecting to post $18.4 billion in sales from its COVID-19 vaccine this year.

Pfizer Inc, which makes the only other vaccine authorized for emergency use in the United States so far, said earlier this month that it was expecting to record sales of about $15 billion in 2021 from the coronavirus vaccine that it makes with German partner BioNTech.

Moderna also said Chief Medical Officer Tal Zaks would leave the company in late September.

Moderna on Wednesday said it was expecting to produce 700 million doses in 2021, while attempting to scale up production to as much as 1 billion doses.

Comments

Comments are closed.